Abbott Unveils Latest Clinical Data on Atrial Fibrillation Treatments at AF Symposium Abbott shares impressive new data on its ablation catheters showcased at the AF Symposium in Boston, reaffirming treatment efficacy for atrial fibrillation patients.

Abbott Unveils Latest Clinical Data on Atrial Fibrillation Treatments at AF Symposium #USA #Boston #Abbott #Volt_PFA #TactiFlex_Duo

Abbott's Volt™ PFA System Shows Promising Long-Term Efficacy for AFib Patients New clinical data from Abbott highlights the long-term safety and effectiveness of its Volt™ PFA System for AFib patients, demonstrating significant health benefits.

Abbott's Volt™ PFA System Shows Promising Long-Term Efficacy for AFib Patients #USA #Abbott #Volt_PFA #AFib_Treatment #Abbott_Park,_Illinois

Abbott's Q1 2025 Results Highlight Growth in Diverse Healthcare Sectors Abbott has revealed robust financial results for Q1 2025, showcasing continued growth across multiple sectors, reaffirming their full-year guidance.

Abbott's Q1 2025 Results Highlight Growth in Diverse Healthcare Sectors #United_States #Abbott #Abbott_Park #TriClip #Volt_PFA